Dewei Jiang

1.4k total citations
34 papers, 872 citations indexed

About

Dewei Jiang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Dewei Jiang has authored 34 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Dewei Jiang's work include Epigenetics and DNA Methylation (8 papers), Kruppel-like factors research (6 papers) and Ubiquitin and proteasome pathways (5 papers). Dewei Jiang is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Kruppel-like factors research (6 papers) and Ubiquitin and proteasome pathways (5 papers). Dewei Jiang collaborates with scholars based in China, Hong Kong and United States. Dewei Jiang's co-authors include Ceshi Chen, Jinkui Yang, Ke‐Qin Zhang, Jiali Li, Yunchuan Wang, Wei Zhu, Zhongmei Zhou, Su Hao, Wenjing Liu and Chang Sun and has published in prestigious journals such as Journal of Biological Chemistry, Brain and Oncogene.

In The Last Decade

Dewei Jiang

32 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dewei Jiang China 18 574 171 156 103 82 34 872
Chengwei Zhang China 17 841 1.5× 195 1.1× 167 1.1× 59 0.6× 176 2.1× 46 1.3k
Erin J. Cram United States 20 790 1.4× 197 1.2× 157 1.0× 99 1.0× 19 0.2× 55 1.4k
Duane D. Winkler United States 19 827 1.4× 77 0.5× 90 0.6× 31 0.3× 20 0.2× 27 1.4k
Laurent Paquereau France 18 582 1.0× 132 0.8× 99 0.6× 56 0.5× 62 0.8× 39 931
Gabriel Otero United States 9 998 1.7× 170 1.0× 85 0.5× 77 0.7× 16 0.2× 11 1.3k
Elfriede Dall Austria 15 566 1.0× 85 0.5× 259 1.7× 150 1.5× 10 0.1× 26 929
Daniel R. Dempsey United States 15 468 0.8× 46 0.3× 97 0.6× 32 0.3× 53 0.6× 25 591
Maria A. Theodoraki United States 14 605 1.1× 64 0.4× 63 0.4× 33 0.3× 60 0.7× 22 764
Rosa Farrás Spain 17 1.0k 1.8× 548 3.2× 258 1.7× 135 1.3× 12 0.1× 37 1.5k
Claudia Nieva Spain 13 399 0.7× 87 0.5× 51 0.3× 83 0.8× 74 0.9× 17 649

Countries citing papers authored by Dewei Jiang

Since Specialization
Citations

This map shows the geographic impact of Dewei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei Jiang more than expected).

Fields of papers citing papers by Dewei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dewei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei Jiang. The network helps show where Dewei Jiang may publish in the future.

Co-authorship network of co-authors of Dewei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Dewei Jiang. A scholar is included among the top collaborators of Dewei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dewei Jiang. Dewei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Huichun, Fubing Li, Huan Fang, et al.. (2025). A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth. Signal Transduction and Targeted Therapy. 10(1). 217–217.
2.
Liu, Rui, Jing Zhu, Qianjun He, et al.. (2025). Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer. Advanced Science. 12(16). e2412096–e2412096. 2 indexed citations
4.
Jiang, Dewei, Hongjun Gao, Shuaijia He, Yuan Huang, & Junyong Liu. (2024). A negative-carbon planning method for agricultural rural industrial park integrated energy system considering biomass energy and modern agricultural facilities. Journal of Cleaner Production. 479. 143837–143837. 8 indexed citations
5.
Kong, Yanjie, Tianlong Lan, Gong Chen, et al.. (2024). BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression. Oncogene. 43(39). 2914–2926. 8 indexed citations
7.
Zhang, Hongyan, Longlong Zhang, Dewei Jiang, et al.. (2024). PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer. Cancer Letters. 598. 217112–217112. 19 indexed citations
8.
Liu, Wenjing, Fubing Li, Qiuyun Jiang, et al.. (2024). An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesis. Journal of Advanced Research. 73. 231–245. 2 indexed citations
9.
Qiu, Ting, Lina Zhao, Xinye Wang, et al.. (2023). SGCE promotes breast cancer stemness by promoting the transcription of FGF-BP1 by Sp1. Journal of Biological Chemistry. 299(11). 105351–105351. 5 indexed citations
10.
Cui, Qiuxia, Dewei Jiang, Yuanqi Zhang, & Ceshi Chen. (2023). The tumor-nerve circuit in breast cancer. Cancer and Metastasis Reviews. 42(2). 543–574. 20 indexed citations
11.
Zhao, Ping, Jian Sun, Xinwei Huang, et al.. (2023). Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer. International Journal of Biological Sciences. 19(6). 1861–1874. 18 indexed citations
12.
Kong, Yanjie, Wenlong Ren, Naseer Ali Shah, et al.. (2022). Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer. International Journal of Biological Sciences. 18(5). 2104–2115. 19 indexed citations
13.
Wu, Jiao, Sai‐Ching J. Yeung, Sicheng Liu, et al.. (2021). Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduction and Targeted Therapy. 6(1). 188–188. 41 indexed citations
14.
Zhao, Ping, Dewei Jiang, Yunchao Huang, & Ceshi Chen. (2021). EphA2: A promising therapeutic target in breast cancer. Journal of genetics and genomics. 48(4). 261–267. 39 indexed citations
15.
Sun, Jian, Wenjing Liu, Y. Guo, et al.. (2021). Characterization of tree shrew telomeres and telomerase. Journal of genetics and genomics. 48(7). 631–639. 4 indexed citations
16.
Jiang, Dewei, et al.. (2020). A Comparative Study on 5hmC Targeting Regulation of Neurons in AD Mice by Several Natural Compounds. BioMed Research International. 2020(1). 5016706–5016706. 6 indexed citations
17.
Liu, Wenjing, Peiguo Shi, Zhongmei Zhou, et al.. (2020). TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway. Scientific Reports. 10(1). 1804–1804. 75 indexed citations
18.
Jiang, Dewei, Shu Wei, Fei Chen, Ying Zhang, & Jiali Li. (2017). TET3‐mediated DNA oxidation promotes ATR‐dependent DNA damage response. EMBO Reports. 18(5). 781–796. 47 indexed citations
19.
Jiang, Dewei, Ying Zhang, Ronald P. Hart, et al.. (2015). Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency. Brain. 138(12). 3520–3536. 61 indexed citations
20.
Yang, Jinkui, Yan Yu, Juan Li, et al.. (2013). Characterization and functional analyses of the chitinase-encoding genes in the nematode-trapping fungus Arthrobotrys oligospora. Archives of Microbiology. 195(7). 453–462. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026